White & Case LLP

White & Case LLP houses a specialized and dedicated antitrust practice with significant trial expertise. The team has achieved numerous groundbreaking victories, including recent successes in high-profile securities class action dismissals and a major pharmaceutical antitrust lawsuit. Its practice is further distinguished by international capabilities, leading expertise in the antitrust implications of algorithmic pricing, and deep knowledge of the pharmaceutical sector. J. Mark Gidley and Rebecca Farrington co-chair the practice from Washington DC. Gidley is widely recognized for his defense of clients accused of cartel behavior. Christopher Curran, also based in DC, has an impressive record of victories in jury and bench trials, alongside appellate and Supreme Court experience. Kathryn Mims, another DC-based partner, regularly advises clients on complex multidistrict litigation (MDL) and M&A transactions. Operating from New York, Jack Pace has secured major wins for blue-chip clients across the pharmaceutical, e-commerce, TMT, and asset management industries. DC-based Eric Grannon led the firm’s recent victory in the high-profile ‘pay for delay’ decision in the Second Circuit.
L'éditorial du Legal 500

Témoignages

Collectés indépendamment par l'équipe de recherche du Legal 500.

  • 'Strong ability to learn and translate the nuances of our industry into legal arguments. They build teams with a strong recognition of each individual's strengths. Tenacious yet respectful advocacy on our behalf.'
  • 'Unparalleled responsiveness and engagement.'

Clients clés

  • AbbVie
  • Apex Clearing

Points forts

Led AbbVie to secure dismissal of a 'pay for delay' pharmaceutical antitrust class action.